(Total Views: 403)
Posted On: 02/13/2021 1:13:06 PM
Post# of 153903
Ohm, I didn't see neuropathy explicitly listed on your list of indications -- is it an additional target?
Role of interleukin-4, the chemokine CCL3 and its receptor CCR5 in neuropathic pain, Molecular Immunology, September 2016
www.sciencedirect.com/science/article/abs/pii/S0161589016301547
Maraviroc reduces neuropathic pain through polarization of microglia and astroglia - Evidence from in vivo and in vitro studies, Neuropharmacology, September 2016
https://pubmed.ncbi.nlm.nih.gov/27117708/
Role of interleukin-4, the chemokine CCL3 and its receptor CCR5 in neuropathic pain, Molecular Immunology, September 2016
www.sciencedirect.com/science/article/abs/pii/S0161589016301547
Maraviroc reduces neuropathic pain through polarization of microglia and astroglia - Evidence from in vivo and in vitro studies, Neuropharmacology, September 2016
https://pubmed.ncbi.nlm.nih.gov/27117708/
(0)
(0)
